Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 125 of 361 entries
View as:

Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00091481 Org: User:
Start: 06/30/03 End: - Due: -

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00235833 Org: User:
Start: 06/30/03 End: - Due: -

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00195767 Org: User:
Start: 07/31/04 End: - Due: -

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00062699 Org: User:
Start: 04/30/03 End: - Due: -

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01193140 Org: User:
Start: 07/31/10 End: 11/30/11 Due: 11/30/12

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00053378 Org: User:
Start: 01/31/02 End: - Due: -

Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02415959 Org: User:
Start: 03/31/15 End: 07/31/15 Due: 07/31/16

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002201 Org: User:
Start: - End: - Due: -

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00646386 Org: User:
Start: 03/31/03 End: - Due: -

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Phase: N/A Priority: Normal
NCT ID: NCT01074931 Org: User:
Start: 04/30/08 End: 06/30/10 Due: 06/30/11

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Phase: N/A Priority: Normal
NCT ID: NCT01260844 Org: User:
Start: 04/30/11 End: - Due: -

Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey

Phase: N/A Priority: Normal
NCT ID: NCT01144598 Org: User:
Start: 02/28/10 End: 08/31/11 Due: 08/31/12

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00121017 Org: User:
Start: - End: - Due: -

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Phase: N/A Priority: Normal
NCT ID: NCT01678781 Org: User:
Start: 07/31/12 End: 08/31/13 Due: 08/31/14

A Study of Volociximab in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00369395 Org: User:
Start: 12/31/06 End: 03/31/08 Due: 03/31/09

A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)

Phase: N/A Priority: Normal
NCT ID: NCT00002275 Org: User:
Start: - End: - Due: -

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00235859 Org: User:
Start: 07/31/03 End: - Due: -

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00667576 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00420927 Org: User:
Start: 12/31/06 End: 07/31/10 Due: 07/31/11

Pharmacokinetic Study of ABT-126 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00959634 Org: User:
Start: 08/31/09 End: - Due: -

Creon in HIV Patients With Steatorrhea

Phase: N/A Priority: Normal
NCT ID: NCT00623025 Org: User:
Start: 01/31/09 End: 08/31/09 Due: 08/31/10

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01200160 Org: User:
Start: 02/28/10 End: 05/31/12 Due: 05/31/13

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00036543 Org: User:
Start: 05/31/01 End: - Due: -

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Phase: N/A Priority: Normal
NCT ID: NCT01379703 Org: User:
Start: 02/29/04 End: 02/28/10 Due: 02/28/11

A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Phase: N/A Priority: Normal
NCT ID: NCT01464320 Org: User:
Start: 11/30/11 End: 04/30/12 Due: 04/30/13